LRN analyst estimates
Stride (LRN) analyst ratings, the average price target and its range, and every firm's latest call.
LRN analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 23, 2026 | Barrington | Stride price target lowered to $115 from $125 at Barrington | $115.00 |
| Sep 9, 2026 | BMO Capital | 'Chime Financial (CHYM) to Acquire Stride Bank'; PT Raised to $38 at BMO Capital | $38.00 |
| Jan 28, 2026 | Canaccord Genuity | Canaccord Genuity Reiterates Buy Rating on Stride Inc. (LRN) | $125.00 |
| Jan 28, 2026 | BMO Capital | Stride Inc. (LRN) PT Raised to $94 at BMO Capital | $94.00 |
| Oct 29, 2025 | BMO Capital | BMO downgrades Stride on 'disappointing' fiscal 2026 outlook | $108.00 |
| Aug 29, 2025 | Barrington | Stride price target raised to $185 from $170 at Barrington | $185.00 |
| Apr 30, 2025 | Barrington | Stride price target raised to $170 from $150 at Barrington | $170.00 |
| Oct 24, 2024 | BMO Capital | Stride Inc. (LRN) PT Raised to $88 at BMO Capital | $88.00 |
| Oct 23, 2024 | Canaccord Genuity | Stride Inc. (LRN) PT Raised to $100 at Canaccord Genuity | $100.00 |
| Aug 19, 2024 | Citigroup | Citi downgrades Stride to Neutral amid heightened uncertainty | $90.00 |
| Aug 8, 2024 | BMO Capital | Stride Inc. (LRN) PT Raised to $82 at BMO Capital | $82.00 |
| Apr 25, 2024 | BMO Capital | Stride Inc. (LRN) PT Raised to $73 at BMO Capital | $73.00 |
| Apr 14, 2023 | Barrington | Stride's Favorable Longer-Term Outlook Convinces Analyst To See 30% Upside From Current Levels | $50.00 |
| Aug 25, 2022 | Morgan Stanley | Stride upgraded to Overweight from Equal Weight at Morgan Stanley | $45.00 |
| Apr 20, 2022 | Morgan Stanley | Stride Beats Q3 Expectations; Shares Rise 5.6% | $39.00 |
- 4 firms rate LRN: 2 buy, 2 hold, 0 sell.
- The average price target is $76.50 from 2 analysts, from $38.00 to $115.00.
Updated 2026-11-03 00:00 UTC